Claims for Patent: 5,945,102

Summary for Patent: 5,945,102

Title:	Crustacean and fish derived multifunctional enzyme
Abstract:	The invention relates to a multifunctional enzyme that can be derived from crustaceans or fish. The enzyme has at least one of a chymotrypsin, trypsin, elastase, collagenase and exo peptidase activity, and a molecular weight between about 20 kd and about 40 kd. Preferably, the multifunctional enzyme has substantial anti cell-cell adhesion activity. Preferably, the multifunctional enzyme has substantial homology with the krill multifunctional enzyme. These enzymes are useful for treating viral infections such as herpes outbreaks, fungal, bacterial or parasitic infections, including the primary and secondary infections of leprosy, colitis, ulcers, hemorrhoids, corneal scarring, dental plaque, acne, cystic fibrosis, blood clots, wounds, immune disorders including autoimmune disease and cancer. Additionally, the invention relates to a method of purifying the multifunctional enzyme, and to a preparation of essentially purified multifunctional enzyme.
Inventor(s):	de Faire; Johan R. (Vattholma, SE), Franklin; Richard L. (London, GB), Kay; John (Cardiff, GB), Lindblom; Ragnvald (Muang Rayong, TH)
Assignee:	Phairson Medical Inc. (London, GB)
Application Number:	08/385,540
Patent Claims:	1. A method of treating wounds comprising topically administering a composition consisting essentially of, with respect to proteases, krill derived multifunctional enzyme, wherein a wound treating effective amount of multifunctional enzyme is administered and wherein the multifunctional enzyme has endo and exo peptidase activity, a molecular weight of 26,000-32,000 as determined by SDS PAGE and an N-terminal sequence comprising: I-V-G-G-X-E-V-T-P-H-A-Y-P-W-Q-V-G-L-F-L-D-D-M-Y-F (SEQ ID NO: 17) wherein X is any amino aid. 2. The method of claim 1, wherein the enzyme has at least two endopeptidase activities selected from the group consisting of chymotrypsin, trypsin, collagenase and elastase activities. 3. The method of claim 1, wherein the enzyme has at least three of said endopeptidase activities. 4. The method of claim 1, wherein the enzyme has at least four of said endopeptidase activities. 5. The method of claim 1, wherein enzyme has an apparent molecular weight of about 29,000. 6. The method of claim 1, wherein the enzyme has an isoelectric point of approximately 4.0. 7. The method of claim 1, wherein the enzyme has the ability to release free amino acids from casein. 8. The method of claim 7, wherein the enzyme has trypsin and chymotrypsin activity. 9. The method of claim 7, wherein the enzyme has trypsin and collagenase activity. 10. The method of claim 7, wherein the enzyme has chymotrypsin and collagenase activity. 11. The method of claim 7, wherein the enzyme has trypsin, chymotrypsin and collagenase activity. 12. The method of claim 7, wherein the enzyme has trypsin, chymotrypsin, collagenase and elastase activity.

Details for Patent 5,945,102

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965		2016-08-31